Our Science
Our team specializes in cyclic peptide binder design, harnessing the power of AI technology to create cutting-edge solutions.
Our expertise extends to designing agonists from a single protein sequence through our proprietary design process, allowing us to develop cutting-edge pharmaceutical products that cater to specific needs and requirements in a very short time frame.
TARGETS
OUR STORY
Commencing our journey humbly, we are a team with expertise in advanced AI for peptide design and wet lab work, coming together with a shared mission to revolutionize the biotechnology sector. Blending our diverse skills and dedication, we founded Cyclic Therapeutics in a modest laboratory, driven by the vision to drive scientific progress for the betterment of society.
Through unwavering commitment to innovation and collaboration, we have evolved into a renowned biotechnology leader in peptide binder design. Our team's relentless pursuit of excellence and cutting-edge research has propelled us to the forefront of the industry, where we continue to push boundaries and shape the future of biotech.
OUR TEAM
Co-founder
Ass. Professor of Bioinformatics at Stockholm University, cracked structure prediction of protein complexes
Co-founder
Professor of Chemical Biology and Translational Medicine at Karolinska Institutet, inventor of synthetic lethal treatment of cancer with PARP inhibitors
WHY WORK WITH US
Using our unique in silico directed evolution AI approach we can design a potent cyclic peptide to your protein target of choice.
Our design platform enables cyclic peptide design tailored to your needs, when you need it. We tailor aspects such as size, shape or charge directly into the peptide binders.
Join our expert team consisting of top scientists and researchers dedicated to pushing boundaries and achieving remarkable results.
Jobs
We actively recruit personnel at all levels.
Send your resume to contact[at]cyclictx.com
for consideration.
GET IN TOUCH